Screener
Eton Pharmaceuticals, Inc. ETON Inventory Stepup
Inventory Stepup at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept eton:InventoryStepup.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | Three months ended / March 31, 2026 | Three months ended / March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net income (loss) to net cash from (used in) operating activities: | ||
| Stock-based compensation | 1,518 | 1,200 |
| Depreciation and amortization | 1,131 | 1,013 |
| Inventory step-up | 350 | 1,142 |
| Excess and obsolete inventory reserve | 227 | 110 |
| Debt discount amortization and non-cash interest expenses | 118 | 294 |
| Non-cash lease expense | 9 | 17 |
| Other operating activity | 7 | — |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s inventory stepup?
- Eton Pharmaceuticals, Inc. (ETON) reported inventory stepup of $350K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s inventory stepup changed year-over-year?
- Eton Pharmaceuticals, Inc.'s inventory stepup decreased by 69.4% year-over-year, from $1.14M to $350K.
- What does inventory stepup mean?
- Represents the non-cash adjustment to inventory value resulting from purchase price accounting in a business combination. This step-up reflects the fair value adjustment of acquired inventory above its historical cost basis, which is subsequently expensed as the inventory is sold. It is a critical metric for understanding the impact of acquisition accounting on reported cost of goods sold and gross margins.
Ask your AI about Eton Pharmaceuticals, Inc.'s inventory stepup.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude